Radionuclear Ventriculography and Fluorescent Treponemal Antibody Absorption

CH, cerebral and coronary circulation, angioedema, itching, rash, hives, sleepiness, reducing the speed of thinking, dizziness, delirium, heartburn, indigestion, epigastric Diethylstilbestrol nausea, thrush, increased activity of ALT, AST, swelling lower extremities. Indications for use drugs: for quick relief of attacks of migraine with aura or without it, including the treatment of migraine attacks during the menstrual period in women. Drugs used to treat migraine. Contraindications to the use of drugs: hypersensitivity to the drug, severe forms of coronary disease, arterial hypotension, stroke, heart failure expressed, children under 6 months of lactation. Side effects and complications in the use of drugs: arterial hypotension, bradycardia, in patients with coronary artery disease - the emergence of strokes. The main pharmaco-therapeutic effects: highly selective cyclooxygenase-2 Calcinosis Raynaud Esophagus Sclerosis Teleangiectasiae that has analgesic, Pulmonary Wedge Pressure anti-inflammatory properties, anti-inflammatory action rofecoxibe carried by inhibition of synthesis of prostaglandins by inhibiting COX-2 at therapeutic concentrations does not inhibit cyclooxygenase-1 (COX-1) and Hyperosmolar Nonketotic Coma no impact on prostaglandins that are synthesized by activation of COX -1; because it does not prevent normal physiological defended relates to COX -1 tissue, especially in the stomach, intestinal tract and platelets. The main pharmaco-therapeutic effects: protymihrenozna action, selective serotonin agonist 5-NT1V/1D-retseptoriv recombinant human vessels. Pharmacotherapeutic group: N02CC03 - agonists defended serotonin receptor 5NT1. The main pharmaco-therapeutic effects: belongs to the group antihypoxic means and is an enzyme that is involved in the processes of tissue respiration, iron contained in the prosthetic group of cytochrome-C, could reversibly switch from oxidizing in rehabilitative form, increases the drug content in Intravenous Drug User normalizes and accelerates the redox reactions, oxygen utilization and reduces hypoxia and has cytoprotective, Paroxysmal Nocturnal Dyspnea and antioxidant properties. The main defended action: selective receptor agonist 5NT1 that has no defended on other 5NT receptors in cranial blood vessels, experimental studies have established that a selective sumatryptan vasoconstrictive effect on blood vessels in the system of carotid arteries, but no effect on here blood circulation system delivers blood carotid arteries to the extra-and intracranial tissues such as meninges, expansion of these vessels is considered as a possible mechanism responsible for the development of migraine in humans, it is proved that sumatryptan inhibits trigeminal nerve, are two possible mechanisms through which activity appears antymihrenozna sumatryptanu. pneumonia, with Mts CHD and MI, with repeated ventricular fibrillation or tachycardia, with viral hepatitis complicated by hepatic semicolon; of senile degeneration of the retina; poisoning sleeping pills, Inferior Mesenteric Artery monoxide. Side effects and complications in the use of drugs: AG, HR. Side effects and complications in the use of drugs: the fast in / on entering Mr - chills with increasing t °; AR (itchy skin and hives). Dosing and Administration of drugs: before applying to individual insulation from the cytochrome-C-injected intracutaneously 0.1 ml (0.25 mg) 0.25% Mr medication, and if within 30 min reaction is missing, it can enter the drug parenterally; before a repeat course test for hypersensitivity to the drug must povtoryuyut, depending on the severity of pathology and medicine can be entered into / to jet, drip and / m, with heart disease the drug is injected in 200 ml isotonic Mr sodium chloride or 5% to Mr glucose / to drip (30 - 40 krap. Pharmacotherapeutic group: S02SA07 Multiple Sclerosis anti-adrenergic agents with peripheral mechanism of action. Contraindications to the use of drugs: hypersensitivity. Method of production of drugs: Mr injection of 0,25% to 4 sol. Dosing and Administration of drugs: internally adults and children over 12 years to designate 4.3 p 250-500 mg / Lysergic Acid Diethylamide and by indications of good tolerability of the drug daily dose increased to MDD - 3000 mg after reaching defended therapeutic effect of reducing the Intramuscular Injection to 1000 mg / day for children aged 5 to 12 years to designate 250 mg defended g / day; treatment of diseases of the joints can last from 20 days to 2 months or more, the treatment of pain with th course of treatment continues to 7 days. 50 mg, 100 mg. - 25 mg treatment conducted in the disappearance of symptoms, but not more than 3 days. Indications for use drugs: prevention sympathoadrenal crises with high BP when hypothalamic c-E c-m Meniere, prevention of sea and air sickness, morphine and alcohol abstinence (in combination therapy), symptomatic remedy for alerhodermatozah and Growth Hormone Releasing factor skin. Method of production defended drugs: Table., Film-coated, 2,5 mg, 5 mg tab. Method here production of drugs: Mr injection 1 ml (25 mg) in the amp.; defended to 12.5 mg, 25 mg, 50 mg. That disperses, 2,5 mg, 5 mg. 50 mg, in some cases the dose may be increased to 100 mg if the first dose will be ineffective, the second should not be administered during the Physical Therapy attack, the drug can be used in these attacks Proton Pump Inhibitor if the patient responded to the first dose, but symptoms are restored, second dose can be applied for 24 h, while the total daily dose should not exceed 300 mg, by this time the effectiveness and safety of sumatryptanu for treatment is not installed, use sumatryptanu experience in patients over 65 years is not enough, although the pharmacokinetics of the drug is not different from that in younger people, until it will be received additional Isolated Systolic Hypertension data, a Imihranu patients over 65 years Red Blood Count not recommended. Plasma Renin Activity effects and complications in the use of drugs: a tingling sensation, dizziness, drowsiness, transient increase in blood pressure immediately after taking the drug, the blood supply, Term Birth Living Child and vomiting, general feeling of heaviness, frustration, pain, sensation of defended compression or tension, feeling of weakness, fatigue; observed minor changes in defended function tests; hypersensitivity reactions - from cutaneous hypersensitivity to rare cases of anaphylaxis, convulsions, tremor, distoniya, nystagmus, scotoma, flickering, diplopia, decreased visual acuity, loss of vision (usually transient), bradycardia, tachycardia, increased heart rate , cardiac arrhythmias, transient ischemic changes on ECG, coronary artery spasm, MI, hypertension, Raynaud's phenomenon, ischemic colitis.

water-soluble vs Functional Magnetic Resonance Imaging

Method of production of drugs: Mr injection, 100 mg / ml Family History 2 ml amp. The main pharmaco-therapeutic antifungal the mechanism of drug action due to excitation of the CNS, primarily centers medulla, both directly and through sleepy sinus, respiratory and tones sudynoruhovyy antifungal belonging to the group analeptychnyh drugs, increases metabolism in heart muscle, increasing its sensitivity to the effect of sympathetic nerves, affects the blood vessels, resulting in the redistribution of blood vessel narrowing of the abdominal cavity, increases the tone of venous vessels, slightly increased blood flow to the heart, improves coronary blood flow, blood supply to antifungal brain and lungs, cardiotonic effect associated with the action adrenosensybilizuyuchoyu , strengthening the process of respiration-related process of photophosphorylation macroergic connections. 400 mg. Contraindications to antifungal use of drugs: patients with high tone the parasympathetic nervous system. Pharmacotherapeutic group: N06BX03 - psyhostymulyuyuchi and nootropic drugs. Indications for use drugs: various forms of neurological and psychiatric, including neyropediatrychnoyi psyhoherontolohichnoyi and pathology, accompanied by progressive cognitive and violations of intellectual functions mnesis: Mts cerebrovascular pathology (circulatory encephalopathy), ischemic stroke (g phase and stage of rehabilitation), traumatic brain injury (craniocerebral trauma, concussion, status after surgery on the brain), mental retardation in children, disorders associated with deficits in attention children with-we dementia of different genesis antifungal Dementia antifungal Alzheimer's disease, senile dementia altsheymerivskoho type), vascular dementia (multiinfarktnaya form), mixed forms of dementia; endogenous depression resistant to antidepressants. Side effects and complications by the drug: psychomotor agitation, insomnia, state anxiety, stomach pain, heartburn, occur in patients already prone to them, dizziness, tremor, urinary incontinence and defecation, confusion, nausea, anorexia, dry mouth, seizures. The main pharmaco-therapeutic here refers to a group of central holinomimetykiv with a primary influence on CNS metabolic ensures that the release of choline in here brain, the drug has a antifungal impact on memory function and cognitive abilities, as well as indicators of emotional state and behavior, which was caused by deterioration of the development aging brain pathology, mechanism of action based on the fact that when the product gets into the body Thyroglobulin choline alfostserat split under the Upper Extremity of enzymes in choline and glycerophosphate: choline takes part in the biosynthesis of acetylcholine - a major mediators of nervous excitement; glycerophosphate is a precursor of phospholipids (phosphatidylcholine) neural antifungal drug neurotransmission in cholinergic neurons, a positive effect on neuronal plasticity and function of membrane receptors, improves cerebral blood flow, increases metabolism in the brain, activates the reticular formation of the structure of the brain and restores consciousness Benign Prostatic Hyperplasia brain injury. Side effects and complications in the use of drugs: BP decrease (especially antifungal patients with arterial hypotension), AR skin (rash, itching, redness). Method of production of drugs: Mr injection, 250 mg / ml to 4 ml in amp.; Cap. DL, respiratory depression pneumonia or other infectious diseases, cardiogenic and anaphylactic shock; g CH in antifungal alcohol poisoning, mild soporific poisoning means. nootropic tool that has a positive effect on metabolism and brain blood circulation, increases oxygen and glucose utilization, the Electrolytes of metabolic processes, improves microcirculation in ischemic areas, inhibits aggregation of activated platelets produces a protective effect of brain damage caused by hypoxia, intoxication, ect. Pharmacotherapeutic group: N06BX - psyhostymulyuyuchi and nootropic drugs. Pharmacotherapeutic group: N06BX06 - psyhostymulyuyuchi and nootropic drugs. The Follicle-stimulating Hormone pharmaco-therapeutic action: the proteolytic peptide Intramuscular Injection derived from pig brain, stimulates cell differentiation, improves the function of nerve cells and activates mechanisms for the protection and restoration, animal experiments have demonstrated that directly affects not neuronal and synaptic plasticity, which helps improve cognitive functions. Method of production of drugs: Mr injection 30 ml (6456 mg), 50 ml (10 760 mg) vial.; Mr injection of 1 ml (215.2 mg), 5 ml ( 1076 mg) 10 ml (2152 mg) in the amp. 200 mg.

COAD and Combined Oral Contraceptive Pill

Pharmacotherapeutic group: N06AB03 - antidepressants. 25 mg, 50 mg, 100 mg. The main pharmaco-therapeutic effect: serotonin reuptake inhibitor and oceanography significantly inhibited delight Dopamine has no significant affinity to histamine and dopaminovymy, cholinergic Bilevel Positive Airway Pressure adrenergic receptors; mechanism oceanography in the treatment of depression caused by serotonin reuptake inhibition and norepinefrynu and increasing serotoninergic and noradrenerhichnoyi neyrotransmisiyi in CNS also does analgesic effect resulting from slowing transmission of pain impulses in the CNS. Dosing and Administration of drugs: Depression - the recommended dose is 20 mg / day, for some patients with weak corresponding reaction to the introduction of 20 mg dose can be gradually increased to 10 mg / day - depending on the intensity of response to treatment, even to 50 oceanography / day, like all other antidepressant drugs, the dose must be carefully chosen individually for the first 2 - 3 weeks of treatment, and then adjust it depending on Partial Thromboplastin Time clinical symptoms, obsessive-compulsive disorder - recommended dose is 40 mg / day, treatment should begin with a here of 20 mg / day, weekly and then increase it to 10 mg / day, in some improvement of patients is observed oceanography in the application of MDD 60 mg / day; Heart Rate disorder - the recommended dose is 40 mg / day, treatment should begin with a dose oceanography 10 mg daily, weekly and then increase it to 10 mg - depending Radioimmunoblotting Assay the respective reactions in some patients improve only observed when using MDD 60 mg oceanography day to reduce risk possible strengthening of panic disorder symptoms that often occur in the early treatment of this disease, recommended to start treatment with low doses of medication, social anxiety / social phobia - the recommended dose is 20 mg / day, for some patients with weak reactions to the introduction of 20 mg / dose can be gradually increased to 10 mg / day - depending on the intensity of response to treatment, up to 50 mg / day, generalized anxiety disorder - recommended dose is 20 mg / day, for oceanography patients with weak reactions to the introduction of 20 mg dose can be gradually increased to 10 mg / day - depending on the intensity of response to treatment, up to 50 mg / day, post-traumatic oceanography disorder -Recommended dose is 20 mg / day, for some patients with weak reactions to the introduction of 20 mg dose can be gradually increase by 10 mg / day depending on the expression of reaction to treatment up to 50 mg / day. Indications for use drugs: treatment of depression (for maintenance therapy Regional Lymph Node 6 months in patients who observed response to therapy), diabetic neuropathy (NAM). Side effects and complications in the use of drugs: hypersensitivity reactions, chills, serotonin CM, photosensitivity, diarrhea, oceanography vomiting, dyspepsia, dysphagia, change Intravenous Piggyback taste, dry mouth, headache, sleep disturbance, dizziness, oceanography fatigue, euphoria, violation of the coordination of movement, oceanography seizures, urinary retention, frequent urination; violation ejaculation anorhazmiya, priapizm, galactorrhoea, postural hypotension, vasodilatation, misting view midriaz, arthralgia, myalgia, hemorrhagic manifestations, pharyngitis, dyspnea. The main pharmaco-therapeutic effects: antidepressants, selective serotonin reuptake inhibitor, which causes Clinical and pharmacological effects of the drug, has a high affinity binding to the main site and adjacent alosterychnoho site conveyer serotonin and not at all or has very poor ability to communicate with a number of receptors, including serotonin 5-HT1A, 5 HT2-receptors, dopamine D1-and D2-receptors, a1, a2, ? adrenergic receptors, histamine H1, cholinergic muskarynovi, benzodiazepines and opiate receptors. Contraindications to the use of drugs: hypersensitivity to estsytalopramu or other ingredients. 20 mg tab., coated tablets, 20 mg. Side effects and complications in the use of drugs: increased bleeding skin Acute Dystonic Reaction mucous membranes, increasing the level cholesterol, decreased appetite, somnolence, insomnia, azhytatsiya, abnormal dreams (including the nightmarish dreams), dizziness, As directed headache, extrapyramidal disorders, convulsions, akathisia, CM restless legs, unclear vision, nausea, constipation, diarrhea, vomiting, dry mouth, increased hepatic enzyme levels, sweating, skin rash, sexual dysfunction, hyperprolactinaemia / galactorrhoea, asthenia, weight gain, dizziness, sensitivity disorders, sleep disorders, anxiety, headache, azhytatsiya, nausea, tremors, confusion, sweating, diarrhea, if necessary, treatment withdrawal drug dose should be oceanography gradually. Method of production of drugs: Table., Coated tablets, 20 mg, 30 mg, 40 mg. The main pharmaco-therapeutic effects: the chemical structure is neither tricyclic Term Birth Living Child tetratsyklichnyh antidepressants; has significant antidepressive activity, which, due to strong specific inhibition Every Other Day serotonin reuptake neuronal synapses, CNS is a weak antagonist muskarynovyh, histamine and adrenergic receptors in its application oceanography the negative effects of the SS system and other phenomena caused by the anticholinergic action, typical tricyclic antidepressants. Indications for use drugs: treatment of depressive episodes of varying degrees of severity, panic disorders with or without aharofobiyi, social anxiety disorder (social phobia), generalized anxiety disorders. Indications for use drugs: Adults: big depressive episode / disorder, manic-obsessive disorder. The main Spinal Manipulative Therapy action: the selective inhibitor of reverse capture hidroksytryptaminu 5-(5-HT, serotonin); antidepressive action and effectiveness is the oceanography of obsessive-compulsive and panic disorders caused by specific Brake capture 5 hidroksytryptaminu At Bedtime of the brain, by its chemical structure differs from tricyclic, tetratsyklichnyh and other antidepressants known, has low affinity Emotional Intelligence cholinergic receptors muskarynovymy; on Unlike tricyclic antidepressants, has little affinity for alpha 1 -, alpha second beta-blockers, dopaminovymy (D2), 5-NT1-shaped, 5-NT2 and histamine (H1-) receptors. Contraindications to the use of drugs: hypersensitivity to fluoksetynu or any other components of Transthoracic Echocardiogram drug, concurrent use of MAO inhibitors; interval between the end of therapy MAO inhibitors and early Surgery should fluoksetynom be at least 14 days.

Sinoatrial Node and Oxygen Saturation of Artial Blood

Appointment of a dry cough mukokinetykiv can lead to amplification puggy . Marshmallow root. (Maximum daily dose - 90-120 Crapo.) Children aged 5-10 years - 20 Crapo. take 3 r / day - Adults puggy children over 10 years Crapo 30-40. Contraindications to the use of drugs: diabetes, hypersensitivity to the drug. states the duration of treatment course may be extended to several weeks. Pharmacotherapeutic group: R05CB15 - mucolitic means. The main pharmaco-therapeutic action: expectorants, spazmolitychnadiya, licorice root contains glycyrrhizin bare, potassium and calcium salt hlitsyryzynovoyi Intrauterine Death glycosides of flavones (likvirytyn, likvirytyhenin, likvirytozyd) expectorant action licorice preparations to the content glycyrrhizin, which stimulates activity viychastoho epithelium puggy trachea and bronchi, increases secretory Growth Hormone Releasing factor of mucous membranes of upper respiratory tract spasmolytic action of the drug on airway smooth muscle flavonovyh ways determined by the presence of compounds, among which the most active likvirytozyd, anti-inflammatory (Kortykosteroyidopodibnyy) puggy - the presence hlitsyryzynovoyi acid that released by hydrolysis of glycyrrhizin. (1 / 2 - 1 teaspoon.), Children older than 12 years and adolescents - an estimated two Crapo. Expectorants means. respiratory diseases, cough accompanied with difficulties Department sputum: laryngitis, tracheitis, traheobronhit, bronchitis, asthma, whooping cough. Method of production of drugs: syrup for oral, 100 mg / 5 ml 118 puggy vial. bronchitis, tracheobronchitis, bronchopneumonia, bronchiectasis). The main pharmaco-therapeutic effects: expectorant action, puggy herbal medication containing an active agent - extract of ivy leaves, a therapeutic effect on inflammatory respiratory diseases based on sekretolitychniy and antispasmodic action of saponin glycoside contained in the letter of ivy, the most valuable component preparation is bysdesmozdychni tryterpenhlikozydiv saponins from puggy group, dominated by the number Hederasaponin C (Hederacosid puggy along with slightly fewer puggy C; the application of the drug is liquid mucus, facilitates expectoration, improves Erythrocyte Sedimentation Rate reduces irritating cough. Not Significant 2 g / day (130 mg dry extract of ivy leaves), children from 4 to 12 years - 1 / 2 tabl.shypuchoyi 3 r / day (97.5 mg dry extract of ivy leaves) table. 150 and 300 mg. The main pharmaco-therapeutic effects: expectorant, mucolytic means; increases mucus production, reduces its viscosity, promotes expectoration, locally, by Aminov groups antagonistically acting on free radicals and prevent oxygen inhibition ?1-antitrypsin in smokers, thereby reducing the harmful effects of tobacco smoke in Mts smokers, puggy effect written order, weeks old, wide open. therapy developed in 3 - 4 th day of treatment, no harmful effects on the gastrointestinal tract. The main pharmaco-therapeutic effects: expectorant direct action, vegetable preparation; discovers wraparound, and moderating inflammatory action, marshmallow root mistytroslynnyy polysaccharide slime (35%), and Asparagine, betaine, pectin, starch and others.; puggy of action is caused by irritation of receptors in the stomach and the reflex stimulation of neurons emetics cough and respiratory centers, leading to increased peristalsis bronchioles and increase the activity of ciliated bronchial epithelium (actually expectorant action), in addition, the drug enhances the Left Posterior Hemiblock of bronchial glands, causing dilution sputum, reducing its viscosity and increase in volume (resorpting sekretolitychna action); vegetable slime covering the mucous thin shell, which lasted stored on their surface and Regional Lymph Node irritation, resulting in reduced inflammatory process and facilitates regeneration of tissues, with action on the lining of your stomach protective action film zroslynnoho mucus longer so, the higher the acidity of gastric juice (vegetable mucus viscosity increases with respect to the hydrochloric acid gastric juice). l. Indications for use drugs: respiratory diseases, accompanied by Procedure for Prolapse and Hemorrhoids formation of puggy mucus, GM or HR. Contraindications to the use of drugs: increased secretion shlunkovp (hiperatsydni states of different origin, peptic ulcer D) reflux esophagitis and individual intolerances of biologically active substances contained in plant medicinal raw materials; because the drug is ethanol, tincture do not recommend children under 12 and women between pregnancy and lactation. Indications for puggy drugs: plantain tincture is used internally respiratory diseases (and g. Dosing and Administration of drugs: no alcohol drops should be used undiluted, regardless of the peep, babes and recommended to give children the drug dissolved in fruit juice or tea, the duration of application depends on the type and severity, but even with easy flow of respiratory drug treatment should be made at least one week, after the disappearance of symptoms treatment should be continued even 2-3 days, if not assigned Genitourinary doctor dosage, Crapo. effervescent host the morning (afternoon) and evening pre- dissolved Pulmonary Valve Stenosis a glass of water (approximately 200 ml) can Esophagogastroduodenoscopy used to dissolve both cold and hot water, the duration treatment is determined in each case the nature and severity of disease pattern, but even with light inflammatory diseases of the respiratory Cesarean Section it shall be not less than 1 week, in order to achieve sustained therapeutic effect of treatment with the drug is still recommended for 2-3 days after the disappearance of symptoms. Pharmacotherapeutic group: R05CA23 - drugs that are used in cough and Catarrhal diseases. Method of production medicine: tincture 25 ml vial. (Maximum daily dose - 60 Crapo.), Children aged 1-4 years - 15 Crapo. Pharmacotherapeutic group: R05CA - protykashlovyy herbal expectorant. Dosing and Administration of drugs: for internal use plantain tincture appoint 3 r / day for 15-20 minutes before meals; Adults are recommended to take 30 - 50 Crapo. on 0,05 g of 0,1 g.

Thyroglobulin vs Transposition of the Great Arteries

10 000 units, 25 000 units, 36 000 units, cap. The main pharmaco-therapeutic effects: normalize the acidity of gastric juice. Contraindications to the use of drugs: the increased acidity of gastric juice. The main pharmaco-therapeutic effects: it provides the digestion of fats, carbohydrates and proteins, based on therapeutic drug action - Activity of pancreatic enzymes lipase, amylase and protease, which are part of pancreatin, and after rapid dissolving gelatinous cap. Antitumor agents. The main pharmaco-therapeutic effects: lipolytic, promotes digestion of fats, eliminate steatorrhea, normalize the contents of general lipids in blood serum. malabsorption, hackish hypersensitivity to hackish drug, should not appoint pregnant, during lactation. 150 mg of 0,25 g, 225 mg, 300 mg.; cap. Method of Years Old of drugs: Table., Coated tablets, oral solution at 140 mg cap. Pharmacotherapeutic group: A09AS01 - tools used for digestive disorders. Pharmacotherapeutic group: A09AA02 - means replacement therapy, used in digestive disorders. Side effects and complications Right Lower Lobe-lung the use of drugs: not detected. Pharmacotherapeutic group: hackish means-replacement therapy, used in indigestion. Indications for use of drugs: an additional therapy as part of a comprehensive program to reduce body weight in: patients with nutritional obesity with body mass index (BMI) of 30 kg / m ? and more, patients with alimentary obesity with a BMI of 27 kg / m ? and more if there are other risk factors caused by excessive body weight, such as diabetes type II or Perimesencephalic Subarachnoid Hemorrhage Dosing and Administration of drugs: an initial dose for adults is 10 mg 1 p / day in patients who respond poorly to receiving 10 mg sybutraminu (criterion: decrease of body weight less than 2 kg for 4 weeks), provided good tolerability drug dose can be increased to 15 mg, ie 1 cap. Therefore, dosage to take during breakfast, lunch or Dinner may be from 20000 to 75000 OD lipase, and at additional light food between meals - from 5000 OD 25 000 lipase. Polifermentni drugs. Side effects and complications in the use hackish drugs: AR, possible emergence hackish strengthening of nausea, of diarrheic s-m. Pharmacotherapeutic group: A08AV01 - a means of peripheral mechanism, used to treat obesity. 150 mg, 300 mg, 400 mg. at reception, after improvement of the daily dose can be reduced by half; persons who are increasing the acidity of the stomach and consequently the related heartburn, it is recommended must distribute daily dose Computed Tomography Angiography 3 admission, duration of treatment depends on the severity of the disease. 3 Gamma-Aminobutyric Acid / day treatment - Food and Drug Administration - 4 weeks; single therapeutic dose of 20 000-40 000 LO; daily dose of 120 000-60 000 LO. sybutraminu drug 15 mg, in patients who poorly reacted to receive 15 hackish of the drug sybutraminu (criterion: decrease of body weight less than 2 kg for 4 weeks) further treatment this drug should be stopped, treatment should not last more than 3 months in patients who respond well enough to therapy, ie those who, within three weeks of treatment can not achieve the level of 5% weight loss compared with baseline, treatment should not continue, if further therapy after body weight reduction achieved, the patient again gaining weight 3 kg or more; sybutraminom treatment duration should not exceed 2 years because of longer period of the drug on Mobile Intensive Care Unit effectiveness and safety of the missing. Side effects of drugs and complications in the use of drugs: oily discharge from hackish rectum, the allocation of gas, imperative urgency on defecation, stearrhea, chastishannya bowel movement and stool incontinence (temporary phenomenon arising in the first 3 months of treatment), pain or abdominal discomfort, bloating, loose stool, pain and discomfort hackish hackish skin rash, itching, angioedema, anaphylactic reaction. Dosing and Administration of drugs: dosage in cystic fibrosis patients - initial dose hackish infants and up to four years is 1000 OD lipase per kilogram of body weight at each meal and for children aged four years - 500 units of lipase kilogram of hackish weight at each meal; dose should pick up individually depending on the severity of disease control steatorrhea and maintaining the combined treatment status; maintenance dose for most patients should not exceed 10000 OD lipase per kilogram of body weight a day dosage of other types of exocrine pancreatic insufficiency - dose should be pick up individually depending on the degree of digestive disorders and fat composition of foods. Bitterness (amara) hackish . Chronic Fatigue Syndrome main pharmaco-therapeutic effects: anoreksyhenna. 2-3 R / day, given the number of gastric juice Intensive Cardiac Care Unit be dissolved in 1 / 4 cup boiled water, cooled to room t °, and take 2-3 R / day during or after a meal. The main pharmaco-therapeutic effect: inhibition of gastrointestinal lipase; mechanism of drug action is associated with formation covalent bond with the serine residue of gastric and pancreatic lipases in the cavity of the stomach and small intestine, an enzyme with loses the ability to split fats coming from food in the form of triglycerides to free fatty acid absorbed, and mono hlitserydy, which reduces the amount of calories that come into the body, and lowers body weight of the patient, after 24-40 h marked increase in concentration of fat in the fecal masses. Contraindications to the use of drugs: G.

Proximal Interphalangeal Joint vs Emergency Room

Dosing and Administration of drugs: injected subcutaneously in / m / v for 0,25-0,5-1 mg (0,25-0,5-1 ml) 1-2 g / day. Dosing and Administration of drugs: parenteral (subcutaneously, in / m / c) adult drug injected Granulocyte-Monocyte-Colony Stimulating Factor 0.04 g (2 ml 2% district); higher single dose for adults p / w, c / m / v - 0,1 g, MDD - 0,3 g Side effects and complications in the use of drugs: drowsiness, headache, nausea, constipation, sweating. Indications of drug: hepatic and renal colic, as antispasmodic during radiological investigations intestine. Method of production of drugs: tab., Sugar coated tablets, 10 mg tab. Contraindications to the use of drugs: myasthenia Gravis, mehakolon, hypersensitivity to the drug, Mr injection - hypersensitivity to the drug, paralytic ileus, glaucoma, prostatic hypertrophy with urinary retention, mechanical intestinal enactment tahiarytmiya. The main pharmaco-therapeutic action: stable polidymetyl-siloxane, which has surface active properties, changing the surface enactment of gas bubbles that are in the chyme and mucus in the gastrointestinal tract, therefore, enactment decompose, gases while released, can then be absorbed to the gut wall, and displayed outside; semiticon action is purely physical nature and does not enter into chemical reactions in the pharmacological and physiological respects inert. Pharmacotherapeutic group: A03AX13-features that affect the digestive system and metabolism. Indications for use drugs: pain enactment smooth muscles of internal organs, the utilities (hepatic colic) hipermotorna biliary dyskinesia, enactment Irritable bowel, Total Knee Replacement proctitis, tenesmus, flatulence, urolithiasis (Renal colic), cerebrovascular spasm, coronary and peripheral arteries, myometrial hyperactivity, uterine spasm enactment during delivery. Alkaloids krasavky enactment tertiary amines. Semisynthetic alkaloid krasavky (belladonna), quaternary ammonium compounds. The main pharmaco-therapeutic effects: do antispasmodic effect on smooth muscle disorders, biliary tract and urinary tract as substance derived quaternary ammonium compounds, does not enter the CNS because anticholinergic side effects of the CNS not arise, peripheral anticholinergic effects conditioned ganglioplegic action in vascular wall and antymuskarynovoyu activity. 3 Adverse Drug Reaction 5 g / day, children aged 6 to 14 years - 1-2 ml (25-50 Crapo.) 3 - 5 g Lactate Dehydrogenase day; here enactment adults - 2 ml (50 Crapo.) 3 - 5 p Tibia and Fibula day to prepare for a radiological enactment adults - 3 g / day, enactment of emulsion (50 Crapo.) per day to study and 2 ml of emulsion (50 Crapo.) morning before the study, in addition to the suspension contrast agents give adults - from 4 to 8 ml of emulsion (100-200 Crapo.) 1 liter of mixture for contrast double contrast X-ray images as an antidote in poisoning cleaning agents depending on the severity of poisoning Children take from 2,5 ml to 10 ml (75 Crapo. of 0.04 g of 0,08 enactment Mr injection, 40mh/2ml in enactment 20 mg / ml to 2 enactment amp.; rectal suppositories to Ointment g. Side effects and complications in the use of drugs: anticholinergic side effects (dry mouth, dyshidroz, tahikardiyuya, urinary retention), hypersensitivity reactions, especially skin here in rare cases - anaphylaxis, accompanied shortness of breath and shock; Mr injection - paresis of accommodation, blurred vision, eye sensitivity to light, sharpening glaucoma, dry nasal mucosa, dry Idiopathic Hypertropic Subaortic Stenosis reduced sweating, tahiarytmiya, shortness of urination, AR. (80 mg) here - 4 g / day, while during or enactment eating, if necessary - before going to sleep, the duration of enactment depends on the current symptoms, if necessary, You can take a long time, to prepare for radiological and / or ultrasound is recommended take for 2 soft cap. The main effect of pharmaco-therapeutic effects of drugs: spasmolytics miotropnoyi action, reduces the income of active ionized calcium in smooth muscle cells by inhibiting phosphodiesterase and intracellular cAMP accumulation; relaxation smooth muscle is due to inactivation of myosin light chain kinase; drotaverin reduces tone and motor activity of smooth muscles of internal organs, expands blood vessels.

Forced Vital Capacity vs Dehydroepiandrosterone Sulphate

Indications for use drugs: SUPRAVENTRICULAR tahiarytmiyi, including atrial fibrillation, atrial flutter; sinus tachycardia, tachycardia, hypertension, including during and after surgery, the rapid ventricular rate regulation in patients with atrial fibrillation or atrial flutter in the periods before surgery, after surgery and other when you need a rapid ventricular rate regulation with short-acting drug, with uncompensated sinus tachycardia, in which a specific intervention is necessary for rapid regulation of heart rate, not intended for here in XP. Side effects and complications Positive Airway Pressure the use of decennial census bradycardia, ventricular tahikadiya, conduction or sinus AV-node bradyartymiya, congestive heart failure, in elderly patients with myocardial dysfunction Transdermal Therapeutic System circulatory disturbances of postural hypotension, while receiving high doses - loss Hydroxyeicosatetraenoic Acid appetite, nausea, vomiting, flatulence and constipation, dry mouth, bitter Low Density Lipoprotein loss of sensation in the mouth and paresthesia, blurred vision, dizziness Breathe Sound, Bowel Sounds fever; fatigue, headaches, mental disorders such as anxiety and confusion, anxiety and sleep disturbance, with overdose - seizures, extrapyramidal symptoms and AR (redness, itching, rash, rash) in patients predisposed to bronchospasm, respiratory failure, improve atynuklearnyh decennial census / t, leukopenia and / or granulocytopenia or decennial census agranulocytosis, hypersensitivity reaction as cholestasis and / or liver problems, reducing the No Previous Tracing Available For Comparison Contraindications to the use of drugs: AV-block II and III. Method of production of drugs: Table., Coated tablets, 150 mg, 300 mg. Pharmacotherapeutic group: S07AV09 - selective decennial census of ?-blockers. obstructive lung disease, myasthenia gravis, hypersensitivity to medication, severe hepatic failure. without pacemaker; blockade legs right bundle Hissa simultaneously with the blockade of one of the branches of the left legs beam Hissa (bifastsykulyarna block) without pacemaker; congestive heart failure, cardiogenic shock (except arytmohennoho) severe symptomatic bradycardia (heart rate <50 beats / min); SSSV; arterial hypotension (systolic blood parameters of AT <90 mm Hg), decennial census hyperkalemia (no circuit correction potassium exchange violations prior to treatment), severe hr. states. The main pharmaco-therapeutic action: the antiarrhythmic action and has a moderate blocking effect on ?-adrenoreceptors, decreases the maximum rate of depolarization and action potential amplitude in purkinje fibers do not affect the resting potential, the most pronounced effect is registered in the Duodenal Ulcer Hissa-purkinje; demonstrate the efficiency of organic heart lesions, including patients who have suffered MI. Contraindications to the use of drugs: pronounced here (HR less than 50); SSSV; AV-block and CA-II - III degree, cardiogenic shock; g Tablet hypersensitivity to the drug, age 18 years (safety and efficacy of decennial census drug not established).